EP3764988A1 - Gelbildende polypeptide - Google Patents

Gelbildende polypeptide

Info

Publication number
EP3764988A1
EP3764988A1 EP19768400.4A EP19768400A EP3764988A1 EP 3764988 A1 EP3764988 A1 EP 3764988A1 EP 19768400 A EP19768400 A EP 19768400A EP 3764988 A1 EP3764988 A1 EP 3764988A1
Authority
EP
European Patent Office
Prior art keywords
analogs
receptors
gel
peptide
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19768400.4A
Other languages
English (en)
French (fr)
Other versions
EP3764988A4 (de
Inventor
Sheau Yu Teddy Hsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adepthera LLC
Original Assignee
Adepthera LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adepthera LLC filed Critical Adepthera LLC
Publication of EP3764988A1 publication Critical patent/EP3764988A1/de
Publication of EP3764988A4 publication Critical patent/EP3764988A4/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
EP19768400.4A 2018-03-15 2019-03-14 Gelbildende polypeptide Pending EP3764988A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862643593P 2018-03-15 2018-03-15
PCT/US2019/022275 WO2019178359A1 (en) 2018-03-15 2019-03-14 Gel-forming polypeptides

Publications (2)

Publication Number Publication Date
EP3764988A1 true EP3764988A1 (de) 2021-01-20
EP3764988A4 EP3764988A4 (de) 2022-04-20

Family

ID=67907279

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19768400.4A Pending EP3764988A4 (de) 2018-03-15 2019-03-14 Gelbildende polypeptide

Country Status (3)

Country Link
EP (1) EP3764988A4 (de)
CN (1) CN111885999A (de)
WO (1) WO2019178359A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2755815T3 (es) 2016-09-13 2020-04-23 Allergan Inc Composiciones de toxina de Clostridium no proteicas estabilizadas
CN110818790A (zh) * 2019-10-31 2020-02-21 成都圣诺生物制药有限公司 一种替莫瑞林的制备方法
CN113577014B (zh) * 2020-12-30 2023-03-24 广州图微科创生物科技有限公司 医疗器械、水凝胶及其制备方法与应用
CN114181284A (zh) * 2021-11-17 2022-03-15 成都赛恩贝外科学研究院 纳米短肽drf3在药物、nk细胞载体和生物医学的应用
CN114214280B (zh) * 2021-12-20 2022-11-29 南开大学 一种利用自组装多肽衍生物水凝胶培养细胞球体的方法、一种细胞球体及其应用
CN115925975A (zh) * 2022-08-03 2023-04-07 山东大学 一种靶向肿瘤干细胞的car-mφ体内外编辑制备方法以及其应用
WO2024039670A1 (en) 2022-08-15 2024-02-22 Dana-Farber Cancer Institute, Inc. Antibodies against cldn4 and methods of use thereof
CN116270974B (zh) * 2023-03-09 2024-03-12 湖南大学 一种组合物、阿柏西普递送系统和制备方法
CN117511851B (zh) * 2024-01-03 2024-03-26 中国肉类食品综合研究中心 水凝胶支架在细胞培育肉制备中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5958877A (en) * 1995-05-18 1999-09-28 Wimalawansa; Sunil J. Method for counteracting vasospasms, ischemia, renal failure, and treating male impotence using calcitonin gene related peptide
BR0308137A (pt) * 2002-03-04 2005-01-04 Sod Conseils Rech Applic Formulações de droga de liberação constante contendo um peptìdeo veìculo
EP1545287B1 (de) * 2002-10-04 2012-12-05 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES Vasoregulierende verbindungen und anwendungsverfahren
CN102348715B (zh) * 2009-02-03 2017-12-08 阿穆尼克斯运营公司 延伸重组多肽和包含该延伸重组多肽的组合物
CN105079783B (zh) * 2014-05-22 2018-06-19 清华大学深圳研究生院 药物组合物及其制备方法和用途
DE102015000363A1 (de) * 2015-01-20 2016-07-21 Emc Microcollections Gmbh Neue modular funktionalisierbare Peptid-Hydrogele
CN109475604B (zh) * 2016-02-09 2023-04-04 艾得佩索拉公司 长效型clr/ramp激动剂的配量和用途
CN107412150B (zh) * 2017-07-16 2019-07-09 常州大学 一种用于包裹药物的多肽水凝胶的制备方法

Also Published As

Publication number Publication date
WO2019178359A1 (en) 2019-09-19
EP3764988A4 (de) 2022-04-20
CN111885999A (zh) 2020-11-03

Similar Documents

Publication Publication Date Title
US20200405868A1 (en) Gel-forming polypeptides
EP3764988A1 (de) Gelbildende polypeptide
Ding et al. Impact of non-proteinogenic amino acids in the discovery and development of peptide therapeutics
EP2455104B1 (de) Biologisch funktionalisierte, stimulusabhängig lösliche PEG-Hydrogele
Webber et al. Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response
Sánchez-Navarro et al. Using peptides to increase transport across the intestinal barrier
AU2017367173A1 (en) New compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists
HRP990272A2 (en) Water-soluble pharmaceutical composition in an ionic complex and the use thereof
US8906355B2 (en) Synthetic stereoisomer peptides in the retro-inverso and inverso configuration, and with cyclic and linear structure, their polymer conjugates, their encapsulation in polymer particles, and uses thereof
AU2013285470B2 (en) Conjugates containing sequences from placenta growth factor and their use as components of biomaterials and in medicine
US20150273014A1 (en) Use of peptides for promoting wound healing
US20180030093A1 (en) Self-assembling ultrashort aliphatic cyclic peptides for biomedical applications
Sundar et al. Delivery of therapeutics and molecules using self-assembled peptides
JP2022506716A (ja) 抵抗性高血圧に対する併用療法
WO2022129305A1 (en) Pharmaceutical composition of glp-1/glp-2 dual agonists
KR20180119549A (ko) 생리활성폴리펩타이드 결합체의 제조방법
KR20110070850A (ko) 제어 방출성 펩티드 제형
WO2019014559A1 (en) METHOD FOR INCREASING EPITHELIAL PERMEABILITY USING NANOPARTICLES
CA3200526A1 (en) Pharmaceutical composition of glp-1/glp-2 dual agonists
AU2021401137A1 (en) Pharmaceutical composition of glp-1/glp-2 dual agonists
EP4317190A1 (de) C-met-proteinbindender peptidkomplex
US20210163556A1 (en) Bdnf mimetic peptide amphiphiles
KR20230163513A (ko) 세포 내 카고 전달을 위한 합성 펩티드 셔틀제 생체접합체
JP2019522041A (ja) 新規のペプチド及びペプチド模倣体
Chattopadhyay Collagen Mimetic Peptides for Wound Assessment and Healing

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C12P 21/02 20060101ALI20211215BHEP

Ipc: A61K 47/42 20170101ALI20211215BHEP

Ipc: A61K 38/16 20060101ALI20211215BHEP

Ipc: A61K 9/06 20060101ALI20211215BHEP

Ipc: A61K 9/00 20060101ALI20211215BHEP

Ipc: C07K 7/06 20060101ALI20211215BHEP

Ipc: C07K 14/47 20060101ALI20211215BHEP

Ipc: C07K 14/585 20060101ALI20211215BHEP

Ipc: C07K 14/575 20060101AFI20211215BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20220321

RIC1 Information provided on ipc code assigned before grant

Ipc: C12P 21/02 20060101ALI20220315BHEP

Ipc: A61K 47/42 20170101ALI20220315BHEP

Ipc: A61K 38/16 20060101ALI20220315BHEP

Ipc: A61K 9/06 20060101ALI20220315BHEP

Ipc: A61K 9/00 20060101ALI20220315BHEP

Ipc: C07K 7/06 20060101ALI20220315BHEP

Ipc: C07K 14/47 20060101ALI20220315BHEP

Ipc: C07K 14/585 20060101ALI20220315BHEP

Ipc: C07K 14/575 20060101AFI20220315BHEP